2-5A and Virus Infection

  • N. Fujii
Chapter
Part of the Progress in Molecular and Subcellular Biology book series (PMSB, volume 14)

Abstract

Many cells die of viral infections in in vitro systems. Even a far larger organism may succumb if its defenses do not function against a virus. Fortunately, cells and living organisms are provided with various defense mechanisms against viral infection. The most important of these is interferon (IFN), which performs a multitude of functions, particularly in the regulation of cell growth, cell differentiation and immune responses (Gastl and Huber 1988).

Keywords

Human Immunodeficiency Virus Human Immunodeficiency Virus Type Antiviral Activity Vaccinia Virus Measle Virus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aboud M, Hassan Y (1983) Accumulation and breakdown of RNA deficient intracellular virus particles in interferon-treated NIH3T3 cells chronically producing Molony murine leukemia virus. J Virol 45:489–495.PubMedGoogle Scholar
  2. Aguet M (1990) The interferon-γ receptor: a comparison with other cytokine receptors. J Interferon Res 10:551–558.PubMedCrossRefGoogle Scholar
  3. Anderson KP, Fennie EH (1987) Adenovirus early region 1 modulation of interferon antiviral activity. J Virol 61:787–795.PubMedGoogle Scholar
  4. Baczko K, Liebert UG, Cattaneo R, Billeter MA, Roos RP, ter Meulen V (1988) Restriction of measles virus gene expression in measles virus inclusion body encephalitis. J Infect Dis 158:144–150.PubMedCrossRefGoogle Scholar
  5. Baglioni C, Minks MA, Maroney PA (1978) Interferon action may be mediated by activation of a nuclease by pppA2′p5′A2′p5′A. Nature 273:684–687.PubMedCrossRefGoogle Scholar
  6. Baglioni C, D′Alessandro SB, Nilsen TW, den Hartog JAJ, Crea R, van Boom JH (1981) Analogs of (2′-5′)oligo (A): endonuclease activation and inhibition of protein synthesis in intact cells. J Biol Chem 256:3253–3257.PubMedGoogle Scholar
  7. Ball LA (1979) Induction of 2′5′-oligoadenylate synthetase activity and a new protein by chick interferon. Virology 94:282–296.PubMedCrossRefGoogle Scholar
  8. Bayard B, Bisbal C, Silhol M, Cnockaert J, Huez G, Lebleu B (1984) Increased stability and antiviral activity of 2′-O-phosphoglyceryl derivatives of (2′-5′) oligo (adenylate): role of phosphodies-terases and phosphatases in (2′-5′) oligo (adenylate) catabolism. Eur J Biochem 142:291–298.PubMedCrossRefGoogle Scholar
  9. Bayard B, Leserman LD, Bisbal C, Lebleu B (1985) Antiviral activity in L1210 cells of liposome-encapsulated (2′-5′) oligo (adenylate) analogues. Eur J Biochem 151:319–325.PubMedCrossRefGoogle Scholar
  10. Bayard B, Bisbal C, Lebleu B (1986) Activation of ribonuclease L by (2′-5′)(A)4-poly(L-lysine) conjugates in intact cells. Biochemistry 25:3730–3736.PubMedCrossRefGoogle Scholar
  11. Bednarik DP, Mosca JD, Raj NBK, Pitha PM (1989) Inhibition of human immunodeficiency virus (HIV) replication by HIV-traws-activated α2-interferon. Proc Natl Acad Sci USA 86:4958–4962.PubMedCrossRefGoogle Scholar
  12. Benech P, Merlin G, Revel M, Chebath J (1985) The 3′ end structure of the human (2′-5′) oligo A synthetase gene: prediction of two distinct proteins with cell type-specific expression. Nucleic Acids Res 13:1267–1281.PubMedCrossRefGoogle Scholar
  13. Benedetti AD, Pytel BA, Baglioni C (1987) Loss of (2′-5′) oligoadenylate synthetase activity by production of anti-sense RNA results in lack of protection by interferon from viral infections. Proc Natl Acad Sci USA 84:658–662.PubMedCrossRefGoogle Scholar
  14. Bhat RA, Thimmappaya B (1985) Construction and analysis of additional adenovirus substitution mutants confirm the complementation of VAI RNA function by two small RNAs encoded by Epstein-Barr virus. J Virol 56:750–756.PubMedGoogle Scholar
  15. Bischoff JR, Samuel CE (1989) Mechanism of interferon action: activation of the human Pl/eIF-2 protein kinase by individual reovirus s-class mRNAs: sl mRNA is a potent activator relative to s4 mRNA. Virology 172:106–115.PubMedCrossRefGoogle Scholar
  16. Black TL, Safer B, Hovanessian A, Katze MG (1989) The cellular 68,000-Mr protein kinase is highly autophosphorylated and activated yet significantly degraded during poliovirus infection: implications for translational regulation. J Virol 63:2244–2251.PubMedGoogle Scholar
  17. Blanar MA, Baldwin Jr AS, Flavell RA, Sharp PA (1989) A gamma-interferon-induced factor that binds the interferon response of the MHC class I gene, H-2Kb. EMBO J 8:1139–1144.PubMedGoogle Scholar
  18. Boyle JF, Holmes KV (1986) RNA-binding proteins of bovine rotavirus. J Virol 58:561–568.PubMedGoogle Scholar
  19. Capon DJ, Shepard HM, Goeddel DV (1985) Two distinct families of human and bovine interference αgenes are coordinately expressed and encode functional polypeptides. Mol Cell Biol 5:768–779.PubMedGoogle Scholar
  20. Castora FJ, Erickson CE, Kovacs T, Lesiak K, Torrence PF (1991) 2′,5′-Oligoadenylates inhibit relaxation of supercoiled DNA by calf thymus DNA topoisomerase I. J Interferon Res 11:143–149.PubMedCrossRefGoogle Scholar
  21. Cayley PJ, Kerr IM (1982) Synthesis, characterisation and biological significance of (2′-5′) oligoadenylate derivatives of NAD+, ADP-ribose and adenosine (5′) tetraphospho-(5′)aden-osine. Eur J Biochem 122:601–608.PubMedCrossRefGoogle Scholar
  22. Cayley PJ, Knight M, Kerr IM (1982) Virus-mediated inhibition of the ppp (A2′p) A system and its prevention by interferon. Biochem Biophys Res Commun 104:376–382.PubMedCrossRefGoogle Scholar
  23. Cayley PJ, Davies JA, Mccullagh KG, Kerr IM (1984) activation of the ppp (A2′p) nA system in interferon-treated, herpes simplex virus-infected cells and evidence for novel inhibitors of the ppp (A2′p) nA-dependent RNase. Eur J Biochem 143:165–174.PubMedCrossRefGoogle Scholar
  24. Charachon G, Sobol RW, Bisbal C, Salehzada T, Silhol M, Charubala R, Pfleiderer W, Lebleu B, Suhadolnik RJ (1990) Phosphorothioate analogues of (2′-5′) (A) 4: agonist and antagonist activities in intact cells. Biochemistry 29:2550–2556.PubMedCrossRefGoogle Scholar
  25. Chebath J, Benech P, Hovanessian A, Galabru J, Revel M (1987a) Four different forms of interferon-induced 2′,5′-oligo (A) synthetase identified by immunoblotting in human cells. J Biol Chem 262:3852–3857.PubMedGoogle Scholar
  26. Chebath J, Benech P, Revel M, Vigneron M (1987b) Constitutive expression of (2-5′) oligo A synthetase confers resistance to pico ma virus infection. Nature 330:587–588.PubMedCrossRefGoogle Scholar
  27. Clark PA, Sharp NA, Clemens MJ (1990) Translational control by the Epstein-Barr virus small RNA EBER-1. Eur J Biochem 193:635–641.CrossRefGoogle Scholar
  28. Clark PA, Schwemmle M, Schikinger J, Hilse K, Clemens MJ (1991) Binding of Epstein-Barr virus small RNA EBER-1 to the double-stranded RNA-activated protein kinase DAI. Nucleic Acids Res 19:243–248.CrossRefGoogle Scholar
  29. Clemens MJ, Williams BRG (1978) Inhibition of cell-free protein synthesis by pppA2′p5′A2′p5′A: a novel oligonucleotide synthesized by interferon-treated L cell extracts. Cell 13:565–572.PubMedCrossRefGoogle Scholar
  30. Coccia EM, Ferderico M, Romeo G, Affabris E, Cofano F, Rossi GB (1988) Interferons-α,β-and-γ-resistant friend cell variants exhibiting receptor sites for interferons but no induction of 2-5A synthetase and 67K protein kinase. J Interferon Res 8:113–127.PubMedCrossRefGoogle Scholar
  31. Coccia EM, Vaiman D, Raber J, Marziali G, Fiorucci G, Orsatti R, Cohen B, Nissim N, Romeo G, Affabris E, Chebath J, Battistini A (1991) Protein binding to the interferon response enhancer correlates with interferon induction of 2′-5′-oligoadenylate synthetase in normal and interferon-resistant friend cells. J Virol 65:2081–2087.PubMedGoogle Scholar
  32. Crespi M, Chiu M, Schoub BD, Lyons SF (1986) Effect of interferon on Vero cells persistently infected with SSPE virus and lytically infected measles virus. Arch Virol 90:87–96.PubMedCrossRefGoogle Scholar
  33. Crespi M, Chiu M, Struthers JK, Schoub BD, Lyons SF (1988) Effect of interferon on Vero cells persistently infected with Sendai virus compared to Vero cells persistently infected with SSPE virus. Arch Virol 98:235–251.PubMedCrossRefGoogle Scholar
  34. David S, Nissim A, Chebath J, Salzberg S (1989) 2′-5′-Oligoadenylate synthetase gene expression in normal and murine sarcoma virus-transformed NIH 3T3 cells. J Virol 63:1116–1122.PubMedGoogle Scholar
  35. Davies MV, Furtado M, Hershey JWB, Thimmappaya B, Kaufman RJ (1989) Complementation of adenovirus virus-associated RNA I gene deletion by expression of a mutant eukaryotic translation initiation factor, proc Natl Acad Sci USA 86:9163–9167.PubMedCrossRefGoogle Scholar
  36. Davies MV, Elroy-Stein O, Jagus R, Moss B, Kaufman RJ (1992) The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2. J Virol 66:1943–1950.PubMedGoogle Scholar
  37. De Ferra F, Baglioni C (1981) Viral messenger RNA unmethylated in the 5′-terminal guanosine in interferon-treated HeLa cells infected with vesicular stomatitis virus. Virology 112:426–435.PubMedCrossRefGoogle Scholar
  38. Defilippi P, Huez G, Verhaegen-Lewalle M, Clercq ED, Imai J, Torrence P, Content J (1986) Antiviral activity of a chemically stabilized 2-5A analog upon microinjection into HeLa cells. FEBS Lett 198:326–332.PubMedCrossRefGoogle Scholar
  39. Eppstein DA, Marsh YV, Schryver BB, Larsen MA, Barnett JW, Verheyden JPH, Prisbe EJ (1982) Analogs of (A2′p) nA: correlation of structure of analogs of ppp (A2′p) 2A and (A2′p) 2A with stability and biological activity. J Biol Chem 257:13390–13397.PubMedGoogle Scholar
  40. Eppstein DA, Barnatt JW, Marsh YV, Gosselin G, Imbach JL (1983) Xyloadenosine analogue of (A2′p) 2A inhibits replication of herpes simplex viruses 1 and 2. Nature 302:723–724.PubMedCrossRefGoogle Scholar
  41. Federico M, Romeo G, Affabris E, Coccia EM, Rossi GB (1986) 2′,5′-Oligoadenylate synthetase-uninducible alpha/beta-interferon-resistant friend cells develop an antiviral state when permeabilized with lysolecithin and treated with 2′,5′-oligoadenylate oligomers. J Interferon Res 6:233–240.PubMedCrossRefGoogle Scholar
  42. Foster GR, Ackrill AM, Goldin RD, Kerr IM, Thomas HC, Stark GR (1991) Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons α and y and double-stranded RNA. Proc Natl Acad Sci USA 88:2888–2892.PubMedCrossRefGoogle Scholar
  43. Fujihara M, Milligan JR, Kaji A (1989) Effect of 2′,5′-oligoadenylate on herpes simplex virus-infected cells and preventive action of 2′,5′-oligoadenylate on the lethal effect of HSV-2. J Interferon Res 9:691–707.PubMedCrossRefGoogle Scholar
  44. Fujii N, Oguma K (1986) Induction of oligo-2′,5′-adenylate synthetase in human lymphoid cells treated with 5-azacytosine and 5-iododeoxyuridine. J Gen Virol 67:2521–2526.PubMedCrossRefGoogle Scholar
  45. Fujii N, Minagawa T, Kato T, Iida H (1978) Thymidine metabolism in cells treated with DNA-Suppressing factor (DSF). Microbiol Immunol 22:133–141.PubMedGoogle Scholar
  46. Fujii N, Indoh T, Murakami T, Kimura K, Oguma K, Tsukada Y (1988a) Suppression of interferon-induced oligo-2′,5‱-adenylate synthetase induction in human hepatoma cell line, Li-7, Tumor Res 23:103–109.Google Scholar
  47. Fujii N, Oguma K, Kimura K, Yamashita T, Ishida S, Fujinaga K, Yashiki T (1988b) Oligo-2′,5′-adenylate synthetase activity in K562 cell lines persistently infected with measles or mumps virus. J Gen Virol 69:2085–2091.PubMedCrossRefGoogle Scholar
  48. Fujii N, Oguma K, Yamashita T, Fujinaga K, Kakinuma M, Yashiki T (1988c) Decrease of oligo-2′,5′-adenylate synthetase activity in balb3T3 cell persistently infected with Moloney murine leukemia virus. Virus Res 10:303–314.PubMedCrossRefGoogle Scholar
  49. Fujii N, Kwon K, Isogai E, Isogai H, Indoh T, Murakami T, Kimura K, Sekiguchi S, Oguma K (1990a) Effect of interferon on cells persistently infected with human T cell leukemia virus (HTLV-I). Tumor Res 25:1–6.Google Scholar
  50. Fujii N, Kimura K, Murakami T, Indoh T, Ishida S, Fujinaga K, Oguma K (1990b) Suppression of interferon-induced oligo-2′,5′-adenylate synthetase induction in persistent infection. J Gen Virol 71:3071–3074.PubMedCrossRefGoogle Scholar
  51. Fujii N, Kwon K, Yashiki T, Sekiguchi S, Isogai E, Isogai H, Oguma K (1991) Correlation between oligo-2′,5′-adenylate synthetase and expression of human T-lymphotropic virus type-I specific gag protein. Tumor Res 26:11–15.Google Scholar
  52. Fujii N, Kwon K, Yashiki T, Kimura K, Isogai E, Isogai H, Sekiguchi S, Oguma K (1992) O1igo-2′,5′-adenylate synthetase activity in cells persistently infected with human T-lymphotropic virus type-I (HTLV-I). Microbiol Immunol 36:425–429.PubMedGoogle Scholar
  53. Garber EA, Chute HT, Condra JH, Gotlib L, Colonno RJ, Smith RG (1991) Avian cells expressing murine Mxl protein are resistant to influenza virus infection. Virology 180:754–762.PubMedCrossRefGoogle Scholar
  54. Gastl G, Huber C (1988) The biology of interferon actions. Blut 56:193–199.PubMedCrossRefGoogle Scholar
  55. Goswami BB, Crea R, Van Boom JH, Sharma OK (1982) 2′-5′-Linked oligo (adenylic acid) and its analogs: a new class of inhibitors of mRNA methylation. J Biol Chem 257:6867–6870.PubMedGoogle Scholar
  56. Gribaudo G, Lembo D, Cavallo G, Landolfo S, Lengyel P (1991) Interferon action: binding of viral RNA to the 40-kilodalton 2′-5′-oligoadenylate synthetase in interferon-treated HeLa cells infected with encephalomyocarditis virus. J Virol 65:1748–1757.PubMedGoogle Scholar
  57. Grun J, Kroon E, Zoller B, Krempien U, Jungwirth C (1987) Reduced steady-state levels of vaccinia virus-specific early mRNAs in interferon-treated chick embryo fibroblasts. Virology 158:28–33.PubMedCrossRefGoogle Scholar
  58. Gunnery S, Rice AP, Robertson HD, Mathews MB (1990) Tat-responsive region RNA of human immunodeficiency virus 1 can prevent activation of the double-stranded-RNA-activated protein kinase. Proc Natl Acad Sci USA 87:8687–8691.PubMedCrossRefGoogle Scholar
  59. Gutch MJ, Reich NC (1991) Repression of the interferon signal transduction pathway by the adenovirus El A oncogene. Proc Natl Acad Sci USA 88:7913–7917.PubMedCrossRefGoogle Scholar
  60. Haase AT, Gantz D, Eble B, Walker D, Stowring L, Ventura P, Blum H, Wietgrefe S, Zupancic M, Tourtellotte W, Gibbs CJ, Norrby E, Rozenblatt S (1985) Natural history of restricted synthesis and expression of measles virus genes in subacute sclerosing panencephalitis. Proc Natl Acad Sci USA 82:3020–3024.PubMedCrossRefGoogle Scholar
  61. Hannigan GE, Williams BRG (1991) Signal transduction by interferon alpha through arachidonic acid metabolism. Science 251:204–207.PubMedCrossRefGoogle Scholar
  62. Hersh CL, Brown RE, Roberts WK, Swyryd EA, Kerr IM, Stark GR (1984) Simian virus 40-infected, interferon-treated cells contain 2′,5′-oligoadenylates which do not activate cleavage of RNA. J Biol Chem 259:1731–1737.PubMedGoogle Scholar
  63. Higashi Y, Sokawa Y (1982) Microinjection of interferon and 2′,5′-oligoadenylate into mouse L cells and their effects on virus growth. J Biochem 91:2021–2028.PubMedGoogle Scholar
  64. Hovanessian AG, Wood JN (1980) Anticellular and antiviral effects of pppA (2′p5′A) n. Virology 101:81–90.PubMedCrossRefGoogle Scholar
  65. Hovanessian AG, Meurs E, Montagnier L (1981) Lack of systematic correlation between the interferon mediated antiviral state and the levels of 2-5A synthetase and protein kinase in three different types of murine cells. J Interferon Res 1:179–190.PubMedCrossRefGoogle Scholar
  66. Howe G, Steitz JA (1986) Localization of Epstein-Barr virus-encoded small RNA by in situ hybridization. Proc Natl Acad Sci USA 87:8790–8794.Google Scholar
  67. Ilson DH, Torrence PF, Vilcek J (1986) Two molecular weight forms of human 2′,5′-oligoadenylate synthetase have different activation requirements. J Interferon Res 6:5–12.PubMedCrossRefGoogle Scholar
  68. Imai J, Johnston MI, Torrence PF (1982) Chemical modification potentiates the biological activities of 2-5A and its congeners. J Biol Chem 257:12739–12745.PubMedGoogle Scholar
  69. Imani F, Jacobs BL (1988) Inhibitory activity for the interferon-induced protein kinase is associated with the reovirus serotype 1 σ3 protein. Proc Natl Acad Sci USA 85:7887–7891.PubMedCrossRefGoogle Scholar
  70. Kalvakolanu DVR, Bandyopadhyay SK, Harter ML, Sen GC (1991) Inhibition of interferon-inducible gene expression by adeno virus El A proteins: block in transcriptional complex formation. Proc Natl Acad Sci USA 88:7459–7463.PubMedCrossRefGoogle Scholar
  71. Kariko K, Li SW, Sobol RW, Suhadolnik RJ, Charubala R, Pfleiderer W (1987) Phosphorothioate analogues of 2′,5′-oligoadenylate. Activation of 2′,5′-oligoadenylate-dependent endoribonuclease by 2′,5′-phosphorothioate cores and 5′-monophosphates. Biochemistry 26: 7136–7142.PubMedCrossRefGoogle Scholar
  72. Kerr IM, Brown RE (1978) pppA2′p5′A2′p5′A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells. Proc Natl Acad Sci USA 75:256–260.PubMedCrossRefGoogle Scholar
  73. Kerr IM, Stark GR (1991) The control of interferon-inducible gene expression. FEBS Lett 285:194–198.PubMedCrossRefGoogle Scholar
  74. Kimchi A, Shure H, Revel M (1979) Regulation of lymphocyte mitogenesis by (2′-5′) oligoadenylate. Nature 282:849–851.PubMedCrossRefGoogle Scholar
  75. Kitajewski J, Schneider RJ, Safer B, Munemitsu SM, Samuel CE, Thimmappaya B, Shenk T (1986) Adenovirus VAI RNA antogonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2α kinase. Cell 45:195–200.PubMedCrossRefGoogle Scholar
  76. Klein JB, Schepers TM, Dean WL, Sonnenfeld G, McLeish KR (1990) Role of intracellular calcium concentration and protein kinase C activation in IFN-stimulation of U937 cells. J Immunol 144:4305–4311.PubMedGoogle Scholar
  77. Knight M, Cayley PJ, Silverman RH, Wreschner DH, Gilbert CS, Brown RE, Kerr IM (1980) Radioimmune, radiobinding and HPLC analysis of 2-5A and related oligonucleotides from intact cells. Nature 288:189–192.PubMedCrossRefGoogle Scholar
  78. Kumar R, Tiwari RK, Kusari J, Sen GC (1987) Clonal derivatives of the RD-114 cell line differ in their antiviral and gene-inducing responses to interferons. J Virol 61:2727–2732.PubMedGoogle Scholar
  79. Lee C, Suhadolnik RJ (1983) Inhibition of protein synthesis by the cordycepin analog of (2′-5′) ppp (Ap) nA, (2′-5′) ppp (3′dAp) n3′dA, in intact mammalian cells. FEBS Lett 157:205–209.PubMedCrossRefGoogle Scholar
  80. Lee TG, Tomita J, Hovanessian AG, Katze MG (1990) Purification and partial characterization of a cellular inhibitor of the interferon-induced protein kinase of Mr 68,000 from influenza virus-infected cells. Proc Natl Acad Sci USA 87:6208–6212.PubMedCrossRefGoogle Scholar
  81. Leung K, Nabel GJ (1988) HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-kB-like factor. Nature 333:776–778.PubMedCrossRefGoogle Scholar
  82. Lewis JA (1988) Induction of an antiviral state by interferon in the absence of elevated levels of 2,5-oligo (A) synthetase and eIF-2 kinase. Virology 162:118–127.PubMedCrossRefGoogle Scholar
  83. Li SW, Moskow JJ, Suhadolnik RJ (1990) 8-Azido double-stranded RNA photoaffinity probes. J Biol Chem 265:5470–5474.PubMedGoogle Scholar
  84. Longnecker R, Kieff E (1990) A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1. J Virol 64:2319–2326.PubMedGoogle Scholar
  85. Lotz M, Tsoukas CD, Fong S, Carson DA, Vaughan JH (1985) Regulation of Epstein-Barr virus infection by recombinant interferons. Selected sensitivity to interferon-gamma. Eur J Immunol 15:520–525.PubMedCrossRefGoogle Scholar
  86. Lutfalla GL, Gardiner K, Proudhon D, Vielh E, Uze G (1992) The structure of the human interferon α/β receptor gene. J Biol Chem 267:2802–2809.PubMedGoogle Scholar
  87. Marie I, Svab J, Robert N, Galabru J, Hovanessian AG (1990) Differential expression and distinct structure of 69-and 100-kDa forms of 2-5A synthetase in human cells treated with interferon. J Biol Chem 265:18601–18607.PubMedGoogle Scholar
  88. Martin EM, Birdsall NJM, Brown RE, Kerr IM (1979) Enzymic synthesis, characterisation and nuclear-magnetic-resonance spectra of pppA2′p5′A2′p5′A and related oligonucleotides: comparison with chemically synthesised material. Eur J Biochem 95:295–307.PubMedCrossRefGoogle Scholar
  89. Mayer A, Gelderblom H, Kumel G, Jungwirth C (1992) Interferon-γ-induced assembly block in the replication cycle of adenovirus 2: augmentation by tumour necrosis factor-α. Virology 187:372–376.PubMedCrossRefGoogle Scholar
  90. Mellits KH, Kostura M, Mathews MB (1990) Interaction of adenovirus VA RNA1 with the protein kinase DAI: nonequivalence of binding and function. Cell 61:843–852.PubMedCrossRefGoogle Scholar
  91. Meurs E, Hovanessian AG, Montagnier L (1981) Interferon-mediated antiviral state in human MRC5 cells in the absence of detectable levels of 2-5A synthetase and protein kinase. J Interferon Res 1:219–232.PubMedCrossRefGoogle Scholar
  92. Meurs E, Chong K, Galabru J, Thomas NSB, Kerr IM, Williams BRG, Hovanessian AG (1990) Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 62:379–390.PubMedCrossRefGoogle Scholar
  93. Miller CA, Carrigan DR (1982) Reversible repression and activation of measles virus infection in neural cells. Proc Natl Acad Sci USA 79:1629–1633.PubMedCrossRefGoogle Scholar
  94. Montefiori DC, Sobol RW, Li SW, Reichenbach NL, Suhadolnik RJ, Charubala R, Pfleiderer W, Modliszewski A, Robinson WE, Mitchell WM (1989) Phosphorothioate and cordycepin analogues of 2′,5′-oligoadenylate: inhibition of human immunodeficiency virus type 1 reverse transcriptase and infection in vitro. Proc Natl Acad Sci USA 86:7191–7194.PubMedCrossRefGoogle Scholar
  95. Morag A, Tobi M, Ravid Z, Revel M, Schattner A (1982) Increased (2′-5′)-oligo-A synthetase activity in patients with prolonged illness associated with serological evidence of persistent Epstein-Barr virus infection. Lancet 27:744.CrossRefGoogle Scholar
  96. Müller WEG, Weiler BE, Charubala R, Pfleiderer W, Leserman L, Sobol RW, Suhadolnik RJ, Schröder HC (1991) Cordycepin analogues of 2′,5′-oligoadenylate inhibit human immunodeficiency virus infection via inhibition of reverse transcriptase. Biochemistry 30:2027–2033.PubMedCrossRefGoogle Scholar
  97. Nevins JR (1989) Mechanisms of viral mediated trans-activation. In: Maramorosch K, Murphy FA, Shatkin AJ (eds) Advances in virus research vol 37. Academic Press, San Diego, pp 35–83.Google Scholar
  98. Nilsen TW, Maroney PA, Baglioni C (1982) Synthesis of (2′,-5′) oligoadenylate and activation of an endoribounuclease in interferon-treated HeLa cells infected with reovirus. J Virol 42:1039–1045.PubMedGoogle Scholar
  99. Paez E, Esteban M (1984a) Resistance of vaccinia virus to interferon is related to an interference phenomenon between the virus and the interferon system. Virology 134:12–28.PubMedCrossRefGoogle Scholar
  100. Paez E, Esteban M (1984b) Nature and mode of action of vaccinia virus products that block activation of the interferon-mediated ppp (A2′p) nA-synthetase. Virology 134:29–39.PubMedCrossRefGoogle Scholar
  101. Pain VM (1986) Inhibition of protein synthesis in mammalian cells. Biochem J 235:625–637.PubMedGoogle Scholar
  102. Pavlovic J, Zurcher T, Haller O, Staeheli P (1990) Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein. J Virol 64:3370–3375.PubMedGoogle Scholar
  103. Pavlovic J, Haller O, Staeheli P (1992) Human and Mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle. J Virol 66:2564–2569.PubMedGoogle Scholar
  104. Penn LJZ, Williams BRG (1984) Interferon-induced 2-5A synthetase activity in human peripheral blood mononuclear cells after immunization with influenza virus and rubella virus vaccines. J Virol 49:748–753.PubMedGoogle Scholar
  105. Pestka S, Langer JA, Zoon KC, Samuel CE (1987) Interferons and their actions. Annu Rev Biochem 56:727–777.PubMedCrossRefGoogle Scholar
  106. Pfeffer LM, Eisenkraft BL, Reich NC, Improta T, Baxter G, Daniel-Issakani S, Strulovici B (1991) Transmembrane signaling by interferon involves diacylglycerol production and activation of the isoform of protein kinase C in Daudi cells. Proc Natl Acad Sci USA 88:7988–7992.PubMedCrossRefGoogle Scholar
  107. Popik W, Pitha PM (1991) Inhibition by interferon of herpes simplex virus type 1-activated transcription of tat-defective provirus. Proc Natl Acad Sci USA 88:9573–9577.PubMedCrossRefGoogle Scholar
  108. Popik W, Pitha PM (1992) Transcriptional activation of the tat-defective human immunodeficiency virus type-1 provirus: effect of interferon. Virology 189:435–447.PubMedCrossRefGoogle Scholar
  109. Preble OT, Rook AH, Steis R, Silverman RH, Krause D, Quinnan GV, Masur H, Jacob J, Longo D, Gelmann EP (1985) Interferon-induced 2′-5′ oligoadenylate synthetase during interferon therapy in homosexual men with Kaposi′s sarcoma: marked deficiency in biochemical response to interferon in patients with acquired immunodeficiency syndrome. J Infect Dis 152:457–465.PubMedCrossRefGoogle Scholar
  110. Quiroga JA, Mora I, Porres JC, Carreno V (1988) Elevation of 2′,5′-oligoadenylate synthetase activity and HLA-I associated β-microglobulin in response to recombinant interferon-oe administration in chronic HBeAg-positive hepatitis. J Interferon Res 8:755–763.PubMedCrossRefGoogle Scholar
  111. Rataul SM, Hirano A, Wong TC (1992) Irreversible modification of measles virus RNA in vitro by nuclear RNA-unwinding activity in human neuroblastoma cells. J Virol 66:1769–1773.PubMedGoogle Scholar
  112. Reich NC, Pfeffer LM (1990) Evidence for involvement of protein kinase C in the cellular response to interferon alpha. Proc Natl Acad Sci USA 87:8761–8765.PubMedCrossRefGoogle Scholar
  113. Reid LE, Brasnett AH, Gilbert CS, Porter ACG, Gewert DR, Stark GR, Kerr IM (1989) A single DNA response element can confer inducibility by both a-and γ-interferons. Proc Natl Acad Sci USA 86:840–844.PubMedCrossRefGoogle Scholar
  114. Rice AP, Kerr SM, Roberts WK, Brown RE, Kerr IM (1985) Novel 2′,5′-oligoadenylates synthesized in interferon-treated, vaccinia virus-infected cells. J Virol 56:1041–1044.PubMedGoogle Scholar
  115. Rosa MD, Gottlieb E, Lerner MR, Steitz JA (1981) Striking similarities are exhibited by two small Epstein-Barr virus encoded ribonucleic acids and the adenovirus-associated ribonucleic acids VAI and VAIL. Mol Cell Biol 1:785–796.PubMedGoogle Scholar
  116. Rosenblum MG, Cheung L, Kessler D (1988) Differential activity of the 30-kD and the 100-kD forms of 2′-5′ An synthetase induced by recombinant human interferon-α and interferon-γ. Interferon Res 8:275–282.CrossRefGoogle Scholar
  117. Roy S, Katze MG, Parkin N, Edery I, Hovanessian AG, Sonenberg N (1990) Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene product. Science 247:1216–1219.PubMedCrossRefGoogle Scholar
  118. Roy S, Agy M, Hovanessian AG, Sonenberg N, Katze MG (1991) The integrity of the stem structure of human immunodeficiency virus type 1 tat-responsive sequence RNA is required for interaction with the interferon-induced protein kinase. J Virol 65:632–640.PubMedGoogle Scholar
  119. Rysiecki G, Gewert DR, Williams BRG (1989) Constitutive expression of a 2′,5′-oligoadenylate synthetase cDNA results in increased antiviral activity and growth suppression. J Interferon Res 9:649–657.PubMedCrossRefGoogle Scholar
  120. Samuel CE (1991) Antiviral actions of interferon: interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology 183:1–11.PubMedCrossRefGoogle Scholar
  121. Saunders ME, Gewert DR, Tugwell ME, McMahon M, Williams BRG (1985) Human 2-5A synthetase: characterization of a novel cDNA and corresponding gene structure. EMBO J 4:1761–1768.PubMedGoogle Scholar
  122. Sawai H, Imai J, Lesiak K, Johnston MI, Torrence PF (1983) Cordycepin analogues of 2-5A and its derivatives: chemical synthesis and biological activity. J Biol Chem 258:1671–1677.PubMedGoogle Scholar
  123. Schiff LA, Nibert ML, Co MS, Brown EG, Fields BN (1988) Distinct binding sites for zinc and double-stranded RNA in the reovirus outer capsid protein 3. Mol Cell Biol 8:273–283.PubMedGoogle Scholar
  124. Schmidt A, Chernajovsky Y, Shulman L, Federman P, Berissi H, Revel M (1979) An interferon-induced phosphodiesterase degrading (2′-5′) oligoadenylate and C-C-A terminus of tRNA. Proc Natl Acad Sci USA 76:4788–4792.PubMedCrossRefGoogle Scholar
  125. Schneider RJ, Safer B, Munemitsu SM, Samuel CE, Shenk T (1985) Adenovirus VAI RNA prevents phosphorylation of the eukaryotic initiation factor 2α subunit subsequent to infection. Proc Natl Acad Sci USA 82:4321–4325.PubMedCrossRefGoogle Scholar
  126. Schneider-Schaulies S, Liebert UG, Baczko K, ter Meulen V (1990) Restricted expression of measles virus in primary rat astroglial cells. Virology 177:525–534.CrossRefGoogle Scholar
  127. Schröder HC, Wenger R, Kuchino Y, Müller WEG (1989) Modulation of nuclear matrix-associated 2′,5′-oligoadenylate metabolism and ribonuclease L activity in H9 cells by human immunodeficiency virus. J Biol Chem 264:5669–5673.PubMedGoogle Scholar
  128. Sen GC, Lebleu B, Brown GE, Kawakita M, Slattery E, Lengyel P (1976) Interferon, double-stranded RNA and mRNA degradation, Nature 264:370–373.PubMedCrossRefGoogle Scholar
  129. Silverman RH, Cayley PJ, Knight M, Gilbert CS, Kerr IM (1982) Control of the ppp (A2′p) nA system in HeLa cells: effect of interferon and virus infection. Eur J Biochem 124:131–138.PubMedCrossRefGoogle Scholar
  130. Staeheli P (1990) Interferon-induced proteins and the antiviral state. Adv Virus Res 38:147–200.PubMedCrossRefGoogle Scholar
  131. Stellrecht KA, Sperber K, Pogo BGT (1992) Activation of the human immunodeficiency virus type 1 long terminal repeat by vaccinia virus. J Virol 66:2051–2056.PubMedGoogle Scholar
  132. Suhadolnik RJ, Kariko K, Sobol RW, Li SW, Reichenbach NL (1988) 2-and 8-Azido photoaninity probes. 1. Enzymatic synthesis, characterization, and biological properties of 2-and 8-azido photoprobes of 2-5A and photolabeling of 2-5A binding proteins. Biochemistry 27:8840–8846.PubMedCrossRefGoogle Scholar
  133. Swaminathan S, Tomkinson B, Kieff E (1991) Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro. Proc Natl Acad Sci USA 88:1546–1550.PubMedCrossRefGoogle Scholar
  134. Taira H, Yamamoto F, Furusawa M, Sawai H, Kawakita M (1985) Comparative studies on (2′-5′) oligoadenylate-related enzyme systems and the antiviral effect of interferon in two mouse cell lines which differ in (2′-5′) oligoadenylate sensitivity of their protein synthesizing system. J Interferon Res 5:583–596.PubMedCrossRefGoogle Scholar
  135. Taniguchi T (1988) Regulation of cytokine gene expression. Annu Rev Immunol 6:439–464.PubMedCrossRefGoogle Scholar
  136. Thomis DC, Doohan JP, Samuel CE (1992) Mechanism of interferon action: cDNA structure, expression, and regulation of the interferon-induced, RNA-dependent Pl/eIF-2 protein kinase from human cells. Virology 188:33–46.PubMedCrossRefGoogle Scholar
  137. Uze G, Lutfalla G, Gresser I (1990) Genetic transfer of a functional human interferon receptor into mouse cells: cloning and expression of its cDNA. Cell 60:225–234.PubMedCrossRefGoogle Scholar
  138. Vaiman D, Pietrokovsky S, Cohen B, Benech P, Chebath J (1990) Synergism of type I and type II interferons in stimulating the activity of the same DNA enhancer. FEBS Lett 265:12–16.PubMedCrossRefGoogle Scholar
  139. Verhaegen M, Divizia M, Vandenbussche P, Kuwata T, Content J (1980) Abnormal behavior of interferon-induced enzymatic activities in an interferon-resistant cell line. Proc Natl Acad Sci USA 77:4479–4483.PubMedCrossRefGoogle Scholar
  140. Vlach J, Pitha PM (1992) Herpes simplex virus type 1-mediated induction of human immunodeficiency virus type 1 pro virus correlates with binding of nuclear proteins to the NF-KB enhancer and leader sequence. J Virol 66:3616–3623.PubMedGoogle Scholar
  141. Watson JC, Chang H, Jacobs BL (1991) Characterization of a vaccinia virus-encoded double-stranded RNA-binding protein that may be involved in inhibition of the double-stranded RNA-dependent protein kinase. Virology 185:206–216.PubMedCrossRefGoogle Scholar
  142. Weissmann C, Weber H (1986) The interferon genes. Prog Nucleic Acid Res Mol Biol 33:251–300.PubMedCrossRefGoogle Scholar
  143. Whitaker-Dowling P, Youngner J (1983) Vaccinia rescue of VSV from interferon-induced resistance: reversal of translation block and inhibition of protein kinase activity. Virology 131:128–136.PubMedCrossRefGoogle Scholar
  144. Whitaker-Dowling P, Youngner J (1986) Vaccinia-mediate rescue of encephalomyocarditis virus from the inhibitory effects of interferon. Virology 152:50–57.PubMedCrossRefGoogle Scholar
  145. Williams BRG, Kerr IM (1978) Inhibition of protein synthesis by 2′-5′ linked adenine oligonucleo-tides in intact cells. Nature 276:88–90.PubMedCrossRefGoogle Scholar
  146. Williams BRG, Kerr IM, Gilbert CS, White CN, Ball LA (1978) Synthesis and breakdown of pppA2′p5′A2′p5′A and transient inhibition of protein synthesis in extracts from interferon-treated and control cells. Eur J Biochem 92:455–462.PubMedCrossRefGoogle Scholar
  147. Williams BRG, Golgher RR, Brown RE, Gilbert CS, Kerr IM (1979a) Natural occurrence of 2-5A in interferon-treated EMC virus-infected L cells. Nature 282:582–586.PubMedCrossRefGoogle Scholar
  148. Williams BRG, Golgher RR, Kerr IM (1979b) Activation of a nuclease by pppA2′p5′A2′p5′A in intact cells. FEBS Lett 105:47–52.PubMedCrossRefGoogle Scholar
  149. Williams BRG, Saunders ME, Willard HF (1986) Interferon-regulated human 2-5A synthetase gene maps to chromosome 12. Somatic Cell Mol Genet 12:403–408.CrossRefGoogle Scholar
  150. Wood JN, Hovanessian AG (1979) Interferon enhances 2-5A synthetase in embryonal carcinoma cells. Nature 282:74–76.PubMedCrossRefGoogle Scholar
  151. Wreschner DH, McCauley JW, Skehel JJ, Kerr IM (1981) Interferon action-sequence specificity of the ppp (A2′p) nA-dependent ribonuclease. Nature 289:414–417.PubMedCrossRefGoogle Scholar
  152. Wu JM, Chiao JW, Maayan S (1986) Diagnostic value of the determination of an interferon-induced enzyme activity: decreased 2′,5′-oligoadenylate dependent binding protein activity in AIDS patient lymphocytes. AIDS Res 2:127–131.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • N. Fujii
    • 1
  1. 1.Department of MicrobiologySapporo Medical CollegeSapporo 060, HokkaidoJapan

Personalised recommendations